ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,369Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 780

$1.24M Total Retail Price of All Prescriptions

Rank: 30 out of 780

825 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 825 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 825 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 22,655 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,596 1,055 S3 1 1
LEVOTHYROXINE SODIUM 1,146 959 2 5
AMLODIPINE BESYLATE 677 608 3 4
FUROSEMIDE 659 557 4 7
WARFARIN SODIUM 640 592 5 24
SIMVASTATIN 619 522 6 2
LISINOPRIL 597 518 7 6
OMEPRAZOLE 583 441 8 3
CITALOPRAM HBR 562 427 9 23
POTASSIUM CHLORIDE 451 412 10 11
PANTOPRAZOLE SODIUM 409 398 11 25
METFORMIN HCL 394 295 12 8
DONEPEZIL HCL 386 381 13 31
ATENOLOL 368 311 14 21
SERTRALINE HCL 359 311 15 27
GABAPENTIN 353 251 16 13
TRAMADOL HCL 340 315 17 15
CARVEDILOL 334 292 18 14
TRAZODONE HCL 328 277 19 35
NAMENDA 310 310 20 46
METOPROLOL TARTRATE 304 287 21 19
NEXIUM 301 229 22 22
HYDROCHLOROTHIAZIDE 260 213 23 10
ZOLPIDEM TARTRATE 257 177 24 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 247 185 25 26
QUETIAPINE FUMARATE 245 230 26 81
GLYBURIDE 236 178 R 27 101
MELOXICAM 235 202 28 16
METOPROLOL SUCCINATE 222 216 29 20
ATORVASTATIN CALCIUM 201 174 30 12
PRAVASTATIN SODIUM 189 176 31 9
AZITHROMYCIN 185 136 32 38
LOVASTATIN 179 171 33 47
CRESTOR 177 133 34 32
ESCITALOPRAM OXALATE 176 156 35 61
MIRTAZAPINE 174 174 36 58
POLYETHYLENE GLYCOL 3350 173 129 37 79
TAMSULOSIN HCL 168 135 38 36
DIOVAN 167 142 39 55
CLONIDINE HCL 165 152 40 28
DILTIAZEM ER 158 143 41 134
LOSARTAN POTASSIUM 155 154 42 18
CARISOPRODOL 153 46 R 43 67
DIVALPROEX SODIUM 148 131 44 119
RISPERIDONE 145 144 45 98
PREDNISONE 142 113 46 40
HYDRALAZINE HCL 137 121 47 54
DIOVAN HCT 134 116 48 75
SEROQUEL 132 124 49 172
PROMETHAZINE HCL 129 38 R 50 66
AMLODIPINE BESYLATE-BENAZEPRIL 128 102 51 50
CLOPIDOGREL 128 117 51 34
BENAZEPRIL HCL 127 119 53 59
CIPROFLOXACIN HCL 125 112 54 49
FENTANYL 120 87 S2 55 107
DICYCLOMINE HCL 118 98 56 213
DOXYCYCLINE HYCLATE 118 85 56 103
DIGOXIN 111 109 58 56
TRIAMTERENE-HCTZ 110 100 59 37
BUPROPION XL 108 68 60 177
IPRATROPIUM-ALBUTEROL 107 107 61 214
DOXAZOSIN MESYLATE 107 104 61 97
ENALAPRIL MALEATE 106 90 63 64
SPIRONOLACTONE 105 94 64 53
ISOSORBIDE MONONITRATE ER 105 105 64 60
OXYCONTIN 103 57 S2 66 165
AMITRIPTYLINE HCL 102 86 R 67 48
NOVOLOG 99 99 68 158
ONDANSETRON HCL 99 65 68 234
PLAVIX 98 93 70 45
DILTIAZEM 24HR CD 95 88 71 138
OXYCODONE-ACETAMINOPHEN 93 93 S2 72 187
MECLIZINE HCL 93 93 72 83
TRICOR 92 78 74 152
CYCLOBENZAPRINE HCL 91 54 R 75 42
LYRICA 91 81 75 52
METOCLOPRAMIDE HCL 86 72 77 102
OXYCODONE HCL-ACETAMINOPHEN 84 46 S2 78 146
DILTIAZEM 24HR ER 78 59 79 179
CYMBALTA 78 72 79 51
BACLOFEN 78 25 79 153
OXYCODONE HCL 77 0 S2 82 123
VESICARE 76 74 83 186
ALENDRONATE SODIUM 75 74 84 44
MEGESTROL ACETATE 75 75 R 84 161
PREMARIN 74 56 R 86 110
ALLOPURINOL 74 72 86 29
LANTUS 72 72 88 71
VENLAFAXINE HCL ER 72 45 88 117
CARBIDOPA-LEVODOPA 72 72 88 124
FLUOXETINE HCL 71 67 91 65
VENLAFAXINE HCL 70 57 92 226
GLIMEPIRIDE 70 70 92 30
LEVETIRACETAM 69 44 94 130
TRIAMCINOLONE ACETONIDE 69 56 94 154
ROPINIROLE HCL 68 47 96 87
CELEBREX 67 41 97 89
HYDROXYZINE HCL 66 39 R 98 155
SINGULAIR 65 58 99 73
METOLAZONE 65 64 99 195
LIDODERM 64 27 101 224
HUMULIN 70-30 61 43 102 106
OXYBUTYNIN CHLORIDE 60 57 103 148
ACTONEL 59 44 104 264
PROAIR HFA 59 37 104 62
LOSARTAN-HYDROCHLOROTHIAZIDE 58 52 106 33
LEVEMIR 58 58 106 198
PAROXETINE HCL 57 54 108 69
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 44 108 88
ALBUTEROL SULFATE 57 57 108 163
CEFTRIAXONE 56 52 111 278
NADOLOL 55 29 112 253
MORPHINE SULFATE 54 16 S2 113 258
EXELON 54 54 113 132
BISOPROLOL-HYDROCHLOROTHIAZIDE 53 53 115 95
KLOR-CON M20 52 49 116 57
LEVOFLOXACIN 52 46 116 76
GLYBURIDE-METFORMIN HCL 52 52 R 116 108
MORPHINE SULFATE ER 51 12 S2 119 141
FENOFIBRATE 50 25 120 63
NITROFURANTOIN 50 47 120 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.